Surgery Partners, Inc. (NASDAQ:SGRY) Insider Harrison R. Bane Sells 56,315 Shares

Surgery Partners, Inc. (NASDAQ:SGRY) insider Harrison R. Bane sold 56,315 shares of Surgery Partners stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the transaction, the insider now owns 107,037 shares of the company’s stock, valued at approximately $2,744,428.68. The trade was a 34.47 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Surgery Partners Trading Down 0.9 %

NASDAQ SGRY opened at $25.58 on Tuesday. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $35.29. The company has a market capitalization of $3.25 billion, a PE ratio of -53.29, a P/E/G ratio of 17.77 and a beta of 2.60. The stock has a 50-day simple moving average of $21.84 and a 200 day simple moving average of $26.93.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business’s revenue was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.15 earnings per share. Research analysts forecast that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Institutional Investors Weigh In On Surgery Partners

Large investors have recently bought and sold shares of the company. Principal Financial Group Inc. bought a new stake in shares of Surgery Partners in the 3rd quarter valued at $1,469,000. King Street Capital Management L.P. acquired a new position in Surgery Partners in the third quarter valued at about $46,748,000. Royce & Associates LP increased its holdings in shares of Surgery Partners by 12.2% in the third quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after acquiring an additional 55,545 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Surgery Partners by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after purchasing an additional 42,897 shares in the last quarter. Finally, Victory Capital Management Inc. grew its position in shares of Surgery Partners by 140.4% in the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after purchasing an additional 777,038 shares during the period.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on SGRY. Macquarie reaffirmed an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. Bank of America began coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research report on Tuesday, December 3rd. Royal Bank of Canada lowered their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday, November 20th. Finally, UBS Group started coverage on Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $36.56.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.